Learning Objectives

Describe risk factors for HCV, enabling discussions with clients around prevention and harm reduction

Screen, order and interpret tests appropriately to diagnose chronic HCV infection 

Describe the recommended pre-treatment assessment, including liver disease staging  

Determine the appropriate antiviral therapy for treatment of HCV and explain treatment to patient  

Implement monitoring and post-treatment follow-up recommendations 

Target Audience

Addiction medicine physicians, general practitioners, nurse practitioners, and other practitioners prescribing or intending to prescribe s85 DAA medication in alcohol and other drug settings (open also to those working in primary care settings).


This education is a CPD Accredited Activity under the RACGP CPD Program. 40 points allocated.

This course is endorsed by the ACN according to our Continuing Professional Development (CPD) Endorsed Course Standards. It has been allocated 6.5 CPD Hours according to the Nursing and Midwifery Boards of Australia – Continuing Professional Development Standard. 

Date: December 20, 2023 9:00 am

Hepatitis C in Drug and Alcohol Settings - Express Interest

City/Town/Suburb: Online – National
Venue Name: Zoom
Event Status: Proposed
Time Zone: Dependent on jurisdiction